These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34831159)

  • 21. Trehalose enhanced cold atmospheric plasma-mediated cancer treatment.
    Cao X; Fang T; Chen M; Ning T; Li J; Siegel PM; Park M; Chen Z; Chen G
    Biomaterials; 2024 Sep; 309():122582. PubMed ID: 38678699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma.
    Cultrara C; Uhl C; Kirby K; Abed Elrazaq E; Zellander A; Andrews DW; Scott CB; Galluzzi L; Exley MA; Zilberberg J
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37550054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antineoplastic effects of auranofin in canine lymphoma cells.
    Zhang H; Rose BJ; Pyuen AA; Thamm DH
    BMC Cancer; 2018 May; 18(1):522. PubMed ID: 29724201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cold Atmospheric Plasma induces accumulation of lysosomes and caspase-independent cell death in U373MG glioblastoma multiforme cells.
    Conway GE; He Z; Hutanu AL; Cribaro GP; Manaloto E; Casey A; Traynor D; Milosavljevic V; Howe O; Barcia C; Murray JT; Cullen PJ; Curtin JF
    Sci Rep; 2019 Sep; 9(1):12891. PubMed ID: 31501494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study.
    Bakhtiyari-Ramezani M; Nohekhan M; Akbari ME; Abbasvandi F; Bayat M; Akbari A; Nasiri M
    Sci Rep; 2024 Feb; 14(1):3578. PubMed ID: 38347045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
    Van Loenhout J; Flieswasser T; Freire Boullosa L; De Waele J; Van Audenaerde J; Marcq E; Jacobs J; Lin A; Lion E; Dewitte H; Peeters M; Dewilde S; Lardon F; Bogaerts A; Deben C; Smits E
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels.
    Cui XY; Park SH; Park WH
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Auranofin is a potent suppressor of osteosarcoma metastasis.
    Topkas E; Cai N; Cumming A; Hazar-Rethinam M; Gannon OM; Burgess M; Saunders NA; Endo-Munoz L
    Oncotarget; 2016 Jan; 7(1):831-44. PubMed ID: 26573231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
    Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis.
    Hou GX; Liu PP; Zhang S; Yang M; Liao J; Yang J; Hu Y; Jiang WQ; Wen S; Huang P
    Cell Death Dis; 2018 Jan; 9(2):89. PubMed ID: 29367724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms.
    Chen X; Shi X; Zhao C; Li X; Lan X; Liu S; Huang H; Liu N; Liao S; Zang D; Song W; Liu Q; Carter BZ; Dou QP; Wang X; Liu J
    Oncotarget; 2014 Oct; 5(19):9118-32. PubMed ID: 25193854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells.
    Abdalbari FH; Martinez-Jaramillo E; Forgie BN; Tran E; Zorychta E; Goyeneche AA; Sabri S; Telleria CM
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2016 Jan; 35(1):546-51. PubMed ID: 26530353
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Floros KV; Cai J; Jacob S; Kurupi R; Fairchild CK; Shende M; Coon CM; Powell KM; Belvin BR; Hu B; Puchalapalli M; Ramamoorthy S; Swift K; Lewis JP; Dozmorov MG; Glod J; Koblinski JE; Boikos SA; Faber AC
    Cancer Res; 2021 Apr; 81(7):1896-1908. PubMed ID: 33483374
    [No Abstract]   [Full Text] [Related]  

  • 35. The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism.
    Yang M; Liu J; Li J; Wen S; Hu Y; Lu W; Liu J; Huang P; Liu P
    Redox Biol; 2024 Sep; 75():103245. PubMed ID: 38909408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cytotoxicity and immunogenicity of a novel V-jet neon plasma source compared to the kINPen.
    Miebach L; Freund E; Horn S; Niessner F; Sagwal SK; von Woedtke T; Emmert S; Weltmann KD; Clemen R; Schmidt A; Gerling T; Bekeschus S
    Sci Rep; 2021 Jan; 11(1):136. PubMed ID: 33420228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auranofin Mediates Mitochondrial Dysregulation and Inflammatory Cell Death in Human Retinal Pigment Epithelial Cells: Implications of Retinal Neurodegenerative Diseases.
    Yumnamcha T; Devi TS; Singh LP
    Front Neurosci; 2019; 13():1065. PubMed ID: 31649499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin.
    Xiaobo C; Majidi M; Feng M; Shao R; Wang J; Zhao Y; Baladandayuthapani V; Song J; Fang B; Ji L; Mehran R; Roth JA
    Sci Rep; 2016 Nov; 6():35741. PubMed ID: 27845352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells.
    Seo MJ; Kim IY; Lee DM; Park YJ; Cho MY; Jin HJ; Choi KS
    Cell Death Dis; 2023 Jan; 14(1):42. PubMed ID: 36658130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
    Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
    Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.